Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to test the hypothesis that the pregnancy rates of women (ages 18-50
years) undergoing transfer of vitrified-warmed blastocysts (frozen at less than 41 years of
age) as part of their IVF treatment are not different with respect to the administration of
progesterone (Crinone® 8% vaginal gel versus intramuscular progesterone).